Given that ACSS2 requires acetate for nuclear Acetyl-CoA production and sodium butyrate is an HDAC inhibitor, it is highly plausible that acetate and butyrate supplementation may improve cognitive impairments via increasing histone acetylation. This evidence concerns the gene HDAC9 and Cognitive impairment.